Thierry Bernard

Thierry L.
Bernard is Chief Executive Officer & Director at Natixis Immo Développement SA, Chief Executive Officer at QIAGEN Srl, Chairman-Management Board at QIAGEN Gdansk Sp zoo, Chairman at AdvaMedDx since 2023, Chairman at Société des Peintures Europeennes SAS, Director at Huttopia SA, Director at QIAGEN Manchester Ltd. since 2017, Director at First Light Diagnostics, Inc., Director at International Factors Italia SpA, Director at QIAGEN, Inc. (Canada), Director at Bruker Corp.
starting 2026, Chief Financial Officer at Banca Nazionale del Lavoro SpA since 2018, Member at Conseillers du Commerce Extérieur de la France, and Member at French Foreign Trade Advisors.
Former roles include Chief Executive Officer & Managing Director at QIAGEN NV from 2019 to 2026, Chairman at Empruntis SAS, Chairman at Fincorp SAS, Chairman at QIAGEN Marseille SA from 2021 to 2023, Director at Daktari Diagnostics, Inc., Communications Director at TDF SAS, Independent Director at T2 Biosystems, Inc. from 2020 to 2023, Director at HepatoChem, Inc., Director at Business Partner Italia ScpA, Independent Director at Neogen Corp.
from 2024 to 2026, and Vice President-Global Commercial Operations at bioMérieux SA from 2012 to 2014.
Education includes graduate degree from London School of Economics & Political Science in 1988, undergraduate degree from Sciences Po, graduate degree from College of Europe, and undergraduate degree from Harvard Business School in 2009.